Cigarettes and amyotrophic lateral sclerosis: Only smoke or also fire?

Annals of Neurology

Volumn 65, Issue 4, 2009, Pages 361-362

  Weisskopf, Marc G ^a   Ascherio, Alberto ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; FORMALDEHYDE; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; CAUSE OF DEATH; CELL SURVIVAL; CHRONIC DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG EXPOSURE; EDITORIAL; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME POLYMORPHISM; EPIDEMIOLOGY; FOLLOW UP; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GROUPS BY AGE; HAZARD RATIO; HUMAN; IN VITRO STUDY; LONGITUDINAL STUDY; METHODOLOGY; NONHUMAN; OXIDATIVE STRESS; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SWEDEN; NOTE; SMOKING;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; RISK FACTORS; SMOKING;

EID: 65649135083     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21700     Document Type: Editorial

References (14)

1. Gallo V, Bueno-de-Mesquita HB, Vermeulen R, et al. Smoking and risk of amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol 2009;65:378-385.
2. Kamel F, Umbach DM, Munsat TL, et al. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepide- miology 1999;18:194-202.
3. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156-163.
4. Sutedja NA, Veldink JH, Fischer K, et al. Lifetime occupation, education, smoking, and risk of ALS. Neurology 2007;69: 1508-1514.
5. Weisskopf MG, McCullough ML, Calle EE, et al. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 2004;160:26-33.
6. Fang F, Bellocco R, Hernan MA, Ye W. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis-a prospective cohort study. Neuroepidemiology 2006;27:217-221.
7. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69: 541-550.
8. Saeed M, Siddique N, Hung WY, et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 2006;67:771-776.
9. Slowik A, Tomik B, Wolkow PP, et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology 2006;67:766 -770.
10. Wills AM, Landers JE, Zhang H, et al. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology 2008;70:929-934.
11. Lammer EJ, Iovannisci DM, Tom L, et al. Gastroschisis: a gene-environment model involving the VEGF-NOS3 pathway. Am J Med Genet C Semin Med Genet 2008;148C: 213-218.
12. Sathasivam S. VEGF and ALS. Neurosci Res 2008;62:71-77.
13. ATSDR. Toxicological Profile for Formaldehyde. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1999.
14. Weisskopf MG, Morozova N, O'Reilly EJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis mortality. J Neurol Neurosurg Psychiatry (in press).